我想看一级黄色片_欧美性爱无遮挡电影_色丁香视频网站中文字幕_视频一区 视频二区 国产,日本三级理论日本电影,午夜不卡免费大片,国产午夜视频在线观看,18禁无遮拦无码国产在线播放,在线视频不卡国产在线视频不卡 ,,欧美一及黄片,日韩国产另类

首頁(yè) 500強(qiáng) 活動(dòng) 榜單 商業(yè) 科技 領(lǐng)導(dǎo)力 專題 品牌中心
雜志訂閱

美國(guó)加強(qiáng)針獲批,,可能出現(xiàn)這些副作用

Sy Mukherjee
2021-08-20

美國(guó)的聯(lián)邦衛(wèi)生官員在很大程度上仍然對(duì)新冠疫苗加強(qiáng)劑的副作用持觀望態(tài)度,。

文本設(shè)置
小號(hào)
默認(rèn)
大號(hào)
Plus(0條)

新冠疫苗加強(qiáng)劑已經(jīng)在美國(guó)成為現(xiàn)實(shí),。根據(jù)拜登政府于8月18日宣布的一項(xiàng)新的新冠免疫計(jì)劃,從9月20日的一周開始,,所有尚未接種過(guò)輝瑞(Pfizer)或Moderna基于mRNA的第二劑疫苗至少8個(gè)月的美國(guó)成年人,,將可以獲得新冠疫苗增強(qiáng)劑,等待美國(guó)食品與藥品管理局(Food and Drug Administration)和美國(guó)疾病控制中心(Centers for Disease Control)的監(jiān)管批準(zhǔn),。至于注射了強(qiáng)生(Johnson & Johnson)疫苗的人,,相關(guān)潛在加強(qiáng)劑的政策仍然在審查中,因?yàn)閺?qiáng)生的疫苗依賴于另外一種技術(shù),,而非mRNA,。此前,8月13日,,美國(guó)食品與藥品管理局和美國(guó)疾病控制中心已經(jīng)為一些完全接種疫苗的美國(guó)民眾批準(zhǔn)了第一批新冠疫苗增強(qiáng)劑,,盡管其針對(duì)的是一小部分免疫系統(tǒng)受損的美國(guó)民眾。

但在未來(lái)幾個(gè)月,,隨著在技術(shù)上有資格獲得第三劑輝瑞或Moderna新冠疫苗的接種人數(shù)從老年人擴(kuò)大到醫(yī)護(hù)人員,,最終擴(kuò)大到年輕、健康的普通個(gè)人,,以及越來(lái)越多的民眾愿意插隊(duì)去接受第三針加強(qiáng)劑——了解新冠疫苗加強(qiáng)劑的副作用是否與我們?cè)诘谝惠喴呙缱⑸渲锌吹降南嗤?、不同或更?yán)重,將變得十分重要,。

現(xiàn)在,,加強(qiáng)劑的授權(quán)甚至還沒(méi)有到一周,而且還尚未出現(xiàn)足夠的數(shù)據(jù)以表明完全接種疫苗的人在第三次注射后可能會(huì)有什么副作用,。早期指標(biāo)表明,,他們的情況與許多人在最初幾輪疫苗接種后的情況基本一致,但醫(yī)學(xué)專家對(duì)最容易出現(xiàn)非常罕見(jiàn)且相當(dāng)嚴(yán)重的副作用的人群表示擔(dān)憂,。

不同的人經(jīng)歷新冠疫苗副作用的形式不同,,從疲勞、注射部位手臂疼痛,、頭痛,、頭暈,、注射周圍紅腫到幾天后出現(xiàn)的延遲效應(yīng),,例如身體各部位的肌肉疼痛(特別是在注射第二劑mRNA疫苗后)、頭暈,、惡心,、發(fā)冷和發(fā)燒等等。在難受了幾天之后,這些癥狀往往會(huì)消失,。根據(jù)美國(guó)疾病控制中心的說(shuō)法,,這些可能也是加強(qiáng)劑會(huì)產(chǎn)生的情況,人們會(huì)經(jīng)歷一些類似于流感的較溫和的副作用,。

“關(guān)于接受額外劑量疫苗風(fēng)險(xiǎn)的信息有限,,額外劑量新冠疫苗在免疫缺陷人群中的安全性、有效性和益處將繼續(xù)受評(píng)估,?!痹摍C(jī)構(gòu)表示,“到目前為止,,第三劑mRNA疫苗劑量后報(bào)告的反應(yīng)與前兩次劑量相似:注射部位的疲勞和疼痛是最常見(jiàn)的副作用,,且總體上屬于輕到中度。但是,,與兩劑疫苗一樣,,嚴(yán)重的副作用很少,但仍然可能會(huì)發(fā)生,?!?/p>

嚴(yán)重或延遲的副作用尤其需要關(guān)注。據(jù)凱撒健康新聞(Kaiser Health News)報(bào)道,,有證據(jù)表明,,對(duì)于極少數(shù)對(duì)疫苗有危險(xiǎn)反應(yīng)的人來(lái)說(shuō)(比如心肌炎或心臟腫脹),第二次注射后副作用更為常見(jiàn),。第三劑疫苗是否會(huì)擴(kuò)大這一罕見(jiàn)的結(jié)果,,或?qū)е略诩訌?qiáng)劑注射前的免疫過(guò)程中就觀察到的血凝塊和過(guò)敏反應(yīng),目前仍不清楚,。但是,,美國(guó)西北大學(xué)范伯格醫(yī)學(xué)院(Northwestern University Feinberg School of Medicine)的流行病學(xué)家和心臟病學(xué)家薩迪婭?汗等醫(yī)生質(zhì)疑,額外的劑量是否會(huì)使心肌炎的風(fēng)險(xiǎn)更為明顯,,尤其是在年輕和健康的人群中,,他們可能會(huì)產(chǎn)生嚴(yán)重的心臟副作用。此外,,他們還懷疑加強(qiáng)劑的優(yōu)點(diǎn)是否值得這些人冒潛在風(fēng)險(xiǎn),。

在接下來(lái)的幾周和幾個(gè)月里,還有許多關(guān)于加強(qiáng)劑副作用的重要考慮有待追蹤,,包括接受強(qiáng)生疫苗的1300萬(wàn)美國(guó)民眾,。公共衛(wèi)生官員和監(jiān)管機(jī)構(gòu)表示,現(xiàn)在就建議強(qiáng)生疫苗接種者接受加強(qiáng)劑還為時(shí)過(guò)早,,因?yàn)槟壳靶畔⑦€不夠多,。而且這種特殊的疫苗從3月才開始供應(yīng),,這意味著其距離美國(guó)政府8個(gè)月的疫苗補(bǔ)充窗口期還差幾個(gè)月。

“目前還沒(méi)有足夠的數(shù)據(jù)來(lái)確定接受強(qiáng)生公司的楊森(Janssen)新冠疫苗的免疫功能低下人群,,在額外注射相同疫苗后是否也有更好地抗體反應(yīng),。”美國(guó)疾病控制中心表示,。但越來(lái)越多的專家一致認(rèn)為,,每個(gè)人最終都需要加強(qiáng)劑,包括強(qiáng)生疫苗的接種者,。他們擔(dān)心強(qiáng)生疫苗與其他新冠疫苗相比之下的有效性,,以及對(duì)抗新毒株(例如德爾塔變異毒株)的效力。除非強(qiáng)生疫苗獲得更可靠的指導(dǎo)和數(shù)據(jù),,包括加強(qiáng)劑應(yīng)該是強(qiáng)生疫苗的第二劑還是輝瑞或Moderna的mRNA疫苗,,在此之前,官方無(wú)法正式跟蹤這些美國(guó)民眾的加強(qiáng)劑副作用,。

聯(lián)邦衛(wèi)生官員在很大程度上仍然對(duì)新冠疫苗加強(qiáng)劑的副作用持觀望態(tài)度,。他們表示,過(guò)去一周的行動(dòng)表明,,加強(qiáng)劑的潛在好處可能超過(guò)其風(fēng)險(xiǎn),。但是,如果你選擇接種加強(qiáng)劑,,為了獲得額外的保護(hù)而不得不忍受幾天的昏昏沉沉和手臂疼痛,,也請(qǐng)你不要感到驚訝。(財(cái)富中文網(wǎng))

編譯:楊二一

新冠疫苗加強(qiáng)劑已經(jīng)在美國(guó)成為現(xiàn)實(shí),。根據(jù)拜登政府于8月18日宣布的一項(xiàng)新的新冠免疫計(jì)劃,,從9月20日的一周開始,所有尚未接種過(guò)輝瑞(Pfizer)或Moderna基于mRNA的第二劑疫苗至少8個(gè)月的美國(guó)成年人,,將可以獲得新冠疫苗增強(qiáng)劑,,等待美國(guó)食品與藥品管理局(Food and Drug Administration)和美國(guó)疾病控制中心(Centers for Disease Control)的監(jiān)管批準(zhǔn)。至于注射了強(qiáng)生(Johnson & Johnson)疫苗的人,,相關(guān)潛在加強(qiáng)劑的政策仍然在審查中,,因?yàn)閺?qiáng)生的疫苗依賴于另外一種技術(shù),而非mRNA,。此前,,8月13日,美國(guó)食品與藥品管理局和美國(guó)疾病控制中心已經(jīng)為一些完全接種疫苗的美國(guó)民眾批準(zhǔn)了第一批新冠疫苗增強(qiáng)劑,,盡管其針對(duì)的是一小部分免疫系統(tǒng)受損的美國(guó)民眾,。

但在未來(lái)幾個(gè)月,隨著在技術(shù)上有資格獲得第三劑輝瑞或Moderna新冠疫苗的接種人數(shù)從老年人擴(kuò)大到醫(yī)護(hù)人員,,最終擴(kuò)大到年輕,、健康的普通個(gè)人,以及越來(lái)越多的民眾愿意插隊(duì)去接受第三針加強(qiáng)劑——了解新冠疫苗加強(qiáng)劑的副作用是否與我們?cè)诘谝惠喴呙缱⑸渲锌吹降南嗤?、不同或更?yán)重,,將變得十分重要。

現(xiàn)在,,加強(qiáng)劑的授權(quán)甚至還沒(méi)有到一周,,而且還尚未出現(xiàn)足夠的數(shù)據(jù)以表明完全接種疫苗的人在第三次注射后可能會(huì)有什么副作用。早期指標(biāo)表明,,他們的情況與許多人在最初幾輪疫苗接種后的情況基本一致,,但醫(yī)學(xué)專家對(duì)最容易出現(xiàn)非常罕見(jiàn)且相當(dāng)嚴(yán)重的副作用的人群表示擔(dān)憂。

不同的人經(jīng)歷新冠疫苗副作用的形式不同,,從疲勞,、注射部位手臂疼痛、頭痛,、頭暈,、注射周圍紅腫到幾天后出現(xiàn)的延遲效應(yīng),例如身體各部位的肌肉疼痛(特別是在注射第二劑mRNA疫苗后),、頭暈,、惡心、發(fā)冷和發(fā)燒等等,。在難受了幾天之后,,這些癥狀往往會(huì)消失。根據(jù)美國(guó)疾病控制中心的說(shuō)法,,這些可能也是加強(qiáng)劑會(huì)產(chǎn)生的情況,,人們會(huì)經(jīng)歷一些類似于流感的較溫和的副作用。

“關(guān)于接受額外劑量疫苗風(fēng)險(xiǎn)的信息有限,,額外劑量新冠疫苗在免疫缺陷人群中的安全性,、有效性和益處將繼續(xù)受評(píng)估?!痹摍C(jī)構(gòu)表示,,“到目前為止,第三劑mRNA疫苗劑量后報(bào)告的反應(yīng)與前兩次劑量相似:注射部位的疲勞和疼痛是最常見(jiàn)的副作用,,且總體上屬于輕到中度,。但是,與兩劑疫苗一樣,,嚴(yán)重的副作用很少,,但仍然可能會(huì)發(fā)生?!?/p>

嚴(yán)重或延遲的副作用尤其需要關(guān)注,。據(jù)凱撒健康新聞(Kaiser Health News)報(bào)道,,有證據(jù)表明,對(duì)于極少數(shù)對(duì)疫苗有危險(xiǎn)反應(yīng)的人來(lái)說(shuō)(比如心肌炎或心臟腫脹),,第二次注射后副作用更為常見(jiàn),。第三劑疫苗是否會(huì)擴(kuò)大這一罕見(jiàn)的結(jié)果,或?qū)е略诩訌?qiáng)劑注射前的免疫過(guò)程中就觀察到的血凝塊和過(guò)敏反應(yīng),,目前仍不清楚,。但是,美國(guó)西北大學(xué)范伯格醫(yī)學(xué)院(Northwestern University Feinberg School of Medicine)的流行病學(xué)家和心臟病學(xué)家薩迪婭?汗等醫(yī)生質(zhì)疑,,額外的劑量是否會(huì)使心肌炎的風(fēng)險(xiǎn)更為明顯,,尤其是在年輕和健康的人群中,他們可能會(huì)產(chǎn)生嚴(yán)重的心臟副作用,。此外,,他們還懷疑加強(qiáng)劑的優(yōu)點(diǎn)是否值得這些人冒潛在風(fēng)險(xiǎn)。

在接下來(lái)的幾周和幾個(gè)月里,,還有許多關(guān)于加強(qiáng)劑副作用的重要考慮有待追蹤,,包括接受強(qiáng)生疫苗的1300萬(wàn)美國(guó)民眾。公共衛(wèi)生官員和監(jiān)管機(jī)構(gòu)表示,,現(xiàn)在就建議強(qiáng)生疫苗接種者接受加強(qiáng)劑還為時(shí)過(guò)早,,因?yàn)槟壳靶畔⑦€不夠多。而且這種特殊的疫苗從3月才開始供應(yīng),,這意味著其距離美國(guó)政府8個(gè)月的疫苗補(bǔ)充窗口期還差幾個(gè)月,。

“目前還沒(méi)有足夠的數(shù)據(jù)來(lái)確定接受強(qiáng)生公司的楊森(Janssen)新冠疫苗的免疫功能低下人群,在額外注射相同疫苗后是否也有更好地抗體反應(yīng),?!泵绹?guó)疾病控制中心表示。但越來(lái)越多的專家一致認(rèn)為,,每個(gè)人最終都需要加強(qiáng)劑,,包括強(qiáng)生疫苗的接種者。他們擔(dān)心強(qiáng)生疫苗與其他新冠疫苗相比之下的有效性,,以及對(duì)抗新毒株(例如德爾塔變異毒株)的效力,。除非強(qiáng)生疫苗獲得更可靠的指導(dǎo)和數(shù)據(jù),包括加強(qiáng)劑應(yīng)該是強(qiáng)生疫苗的第二劑還是輝瑞或Moderna的mRNA疫苗,,在此之前,,官方無(wú)法正式跟蹤這些美國(guó)民眾的加強(qiáng)劑副作用。

聯(lián)邦衛(wèi)生官員在很大程度上仍然對(duì)新冠疫苗加強(qiáng)劑的副作用持觀望態(tài)度,。他們表示,,過(guò)去一周的行動(dòng)表明,加強(qiáng)劑的潛在好處可能超過(guò)其風(fēng)險(xiǎn),。但是,,如果你選擇接種加強(qiáng)劑,,為了獲得額外的保護(hù)而不得不忍受幾天的昏昏沉沉和手臂疼痛,也請(qǐng)你不要感到驚訝,。(財(cái)富中文網(wǎng))

編譯:楊二一

COVID vaccine boosters are now a reality in America. Under a new Biden administration coronavirus immunization plan announced Aug. 18, COVID-19 boosters would be made available to all fully vaccinated U.S. adults who are at least eight months out from getting their second dose of Pfizer's or Moderna's mRNA-based jabs beginning the week of Sept. 20, pending regulatory blessings from the Food and Drug Administration (FDA) and the Centers for Disease Control (CDC). The policy regarding potential boosters for those who received one dose of Johnson & Johnson's shot, which relies on a different kind of technology, is still under review. The FDA and CDC already green-lit the first batch of COVID booster shots for some fully vaccinated Americans on Aug. 13, albeit for a tiny slice of the American populace who have compromised immune systems.

But as the number of vaccinated people technically eligible to get a third dose of Pfizer's or Moderna's two-dose COVID vaccines swells in the coming months from the elderly to health care workers and eventually to young, healthy individuals—or as more people become willing to jump the line and get themselves a booster early like more than 1 million Americans already have—it will be important to keep track of whether or not COVID boosters have the same, different, or more severe side effects than what we've seen with the initial round of shots.

Booster shots haven't even been authorized for a full week, and there's not much data yet on what side effects fully vaccinated people could experience with a third dose. The early indicators suggest they're largely in line with what many experienced after their initial rounds of vaccination, but medical experts have some concerns about those most at risk for very rare but serious side effects.

Different people experience COVID vaccine side effects differently, and they run the gamut from fatigue, arm pain at the injection site, headache, dizziness, and redness and swelling around the injection to delayed effects that present a few days later, like muscle pain in various body parts (particularly after the second dose of an mRNA vaccine), loopiness, nausea, chills, and fever. Those symptoms tend to go away within a day or two but can be unpleasant for those few days. That could be the case for booster doses, too, with people experiencing some milder side effects that resemble the flu, according to the CDC.

"There is limited information about the risks of receiving an additional dose of vaccine, and the safety, efficacy, and benefit of additional doses of COVID-19 vaccine in immunocompromised people continues to be evaluated," per the agency. "So far, reactions reported after the third mRNA dose were similar to that of the two-dose series: fatigue and pain at injection site were the most commonly reported side effects, and overall, most symptoms were mild to moderate. However, as with the two-dose series, serious side effects are rare, but may occur."

Serious or delayed side effects will be particularly important to keep an eye on. There is some evidence that for the very small number of people who experience dangerous reactions to the vaccines such as myocarditis, or heart swelling, the side effect was more common after a second dose, Kaiser Health News reports. Whether or not a third dose could amplify that rare outcome or cause blood clots and allergic reactions that have been observed in some during the pre-booster immunization process is still unknown. But physicians such as Northwestern University Feinberg School of Medicine epidemiologist and cardiologist Sadiya Khan question whether the myocarditis risk specifically could become more pronounced with additional doses, especially among younger and healthier people who could develop the serious cardiac side effect, and whether a booster's benefit is worth the potential risk for those individuals.

There are still many important considerations about booster side effects left to track in coming weeks and months, including for the 13 million Americans who received Johnson & Johnson's COVID vaccine. Public health officials and regulators say it's too early to advise J&J shot recipients on what to do about a booster because there isn't enough information yet. And that particular vaccine has been available only since March, which means it falls a few months short of the administration's eight month post-vaccination window for a booster.

"There is not enough data at this time to determine whether immunocompromised people who received the Johnson & Johnson’s Janssen COVID-19 vaccine also have an improved antibody response following an additional dose of the same vaccine," per the CDC. But there is growing expert consensus that everyone will eventually need a booster dose, including J&J recipients who have concerns about its effectiveness compared to other COVID vaccines and potency against new coronavirus strains like the Delta variant. It won't be possible to officially track booster side effects for these Americans until there's more solid guidance and data around the J&J vaccine, including whether a booster should be a second dose of the Johnson & Johnson product or one of Pfizer's or Moderna's mRNA jabs.

Federal health officials largely remain in wait-and-see mode on COVID booster side effects and have signaled the potential benefits of boosters likely outweigh their risks through the past week's actions. But if you are someone who qualifies for an additional shot, don't be surprised if you have to deal with a few days of grogginess and arm pain in exchange for the added protection.

財(cái)富中文網(wǎng)所刊載內(nèi)容之知識(shí)產(chǎn)權(quán)為財(cái)富媒體知識(shí)產(chǎn)權(quán)有限公司及/或相關(guān)權(quán)利人專屬所有或持有,。未經(jīng)許可,禁止進(jìn)行轉(zhuǎn)載,、摘編,、復(fù)制及建立鏡像等任何使用,。
0條Plus
精彩評(píng)論
評(píng)論

撰寫或查看更多評(píng)論

請(qǐng)打開財(cái)富Plus APP

前往打開
熱讀文章